Close
Nordic 9Nordic 9

Subversive Capital (investor - Venture Capital)

United States subversivecapital.com
See something wrong or missing? Let us know
Offices:New York

Subversive Capital, owned by Michael Auerbach, specializes in investing in disruptive companies that require regulatory advisement.

Average round investment:101M USD
Average number per year:1.0
Distribution: 2021 (1)2019 (1)
Portfolio companies: Germany Atai Life Sciences
Mostly invests in: Germany Germany (2) Big Data (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Subversive Capital

Name Criteria
United States Hercules Capital
79%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
United States Thiel Capital
79%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Big Data, Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
United States Fearless Ventures
79%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Big Data, Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
United States Falcon Edge Capital
79%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Big Data, Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
United States Pura Vida Pro LLC
79%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Big Data, Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
United States Highline Capital
79%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Big Data, Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
United States Patient Square Capital
79%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Big Data, Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
Switzerland Korify Capital
79%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Big Data, Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
Germany Vogel Ventures GmbH
79%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Big Data, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.2
Switzerland HBM Healthcare Investments
79%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.3
Top